Peng, M., Rios, G., Estevez, M., Colasurdo, J., Forouzanfar, M., Hoang, K., Wang, M. (2026). Using ML to predict rapid progression for patients (pts) with HR+/HER2- metastatic breast cancer (mBC) treated with frontline (1L) CDK 4/6 inhibitors (CDK 4/6i).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.1025